Risk ‐adapted GVHD prophylaxis with post‐transplantation cyclophosphamide in adults after related, unrelated and haploidentical transplantations

ConclusionThe suggested risk‐adapted PTCy‐based prophylaxis is feasible and is associated with low GVHD incidence and mortality in all types of grafts. The study was registered on clinicaltrials. gov (NCT02294552).This article is protected by copyright. All rights reserved.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fejh.13030

Source: European Journal of Haematology - January 23, 2018 Category: Hematology Authors: Ivan S. Moiseev, Olga V. Pirogova, Alexandr L. Alyanski, Elena V. Babenko, Tatyana L. Gindina, Elena I. Darskaya, Olga A. Slesarchuk, Tatyana A. Bykova, Alexei B. Chukhlovin, Dmitrii E. Pevtcov, Sergey N. Bondarenko, Boris V. Afanasyev Tags: Original Article Source Type: research